tradingkey.logo
tradingkey.logo

Merit Medical Systems Inc

MMSI
87.390USD
-0.240-0.27%
終値 12/24, 16:00ET15分遅れの株価
5.18B時価総額
43.52直近12ヶ月PER

Merit Medical Systems Inc

87.390
-0.240-0.27%

詳細情報 Merit Medical Systems Inc 企業名

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.

Merit Medical Systems Incの企業情報

企業コードMMSI
会社名Merit Medical Systems Inc
上場日Oct 22, 2090
最高経営責任者「CEO」Aronson (Martha Goldberg)
従業員数7400
証券種類Ordinary Share
決算期末Oct 22
本社所在地1600 West Merit Park Way
都市SOUTH JORDAN
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号84095
電話番号18012531600
ウェブサイトhttps://www.merit.com/
企業コードMMSI
上場日Oct 22, 2090
最高経営責任者「CEO」Aronson (Martha Goldberg)

Merit Medical Systems Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
16.61K
--
Rear Adm. (Retd.) Stephen C. Evans
Rear Adm. (Retd.) Stephen C. Evans
Independent Director
Independent Director
6.81K
+46.21%
Mr. Michael R. (Mike) McDonnell, CPA
Mr. Michael R. (Mike) McDonnell, CPA
Independent Director
Independent Director
3.96K
-30.63%
Dr. F. Ann Millner, Ed.D.
Dr. F. Ann Millner, Ed.D.
Lead Independent Director
Lead Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%
地域別USD
会社名
収益
比率
United States
227.08M
59.37%
International
155.38M
40.63%
事業別
地域別
事業別USD
会社名
収益
比率
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%

株主

更新時刻: Tue, Nov 18
更新時刻: Tue, Nov 18
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
他の
64.97%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
他の
64.97%
種類
株主統計
比率
Investment Advisor
54.11%
Investment Advisor/Hedge Fund
32.95%
Hedge Fund
10.11%
Research Firm
3.04%
Bank and Trust
2.31%
Individual Investor
2.26%
Pension Fund
1.63%
Sovereign Wealth Fund
1.02%
Family Office
0.40%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
736
64.29M
108.43%
-3.60M
2025Q2
756
65.62M
110.80%
-760.05K
2025Q1
779
66.66M
112.79%
+221.37K
2024Q4
755
63.98M
108.78%
+576.77K
2024Q3
725
62.16M
106.75%
-1.49M
2024Q2
695
63.02M
108.42%
-345.52K
2024Q1
677
61.08M
105.16%
-692.46K
2023Q4
651
59.77M
103.51%
-88.47K
2023Q3
637
57.87M
100.40%
-723.38K
2023Q2
625
56.54M
98.35%
-2.22M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
7.97M
13.46%
-206.62K
-2.53%
Jun 30, 2025
The Vanguard Group, Inc.
6.82M
11.51%
+257.10K
+3.92%
Jun 30, 2025
State Street Investment Management (US)
2.22M
3.75%
+24.57K
+1.12%
Jun 30, 2025
Conestoga Capital Advisors, LLC
2.21M
3.73%
-53.58K
-2.37%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.82M
3.07%
+52.67K
+2.98%
Jun 30, 2025
Maverick Capital, Ltd.
1.38M
2.33%
+106.90K
+8.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.44M
2.43%
+39.62K
+2.83%
Jun 30, 2025
Nomura Investment Management Business Trust
1.46M
2.46%
+4.15K
+0.29%
Jun 30, 2025
Fidelity Institutional Asset Management
1.09M
1.85%
-3.11K
-0.28%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Tue, Dec 2
更新時刻: Tue, Dec 2
銘柄名
比率
Invesco S&P SmallCap Health Care ETF
3.18%
First Trust Indxx Medical Devices ETF
2.22%
State Street SPDR S&P Health Care Equipment ETF
1.76%
Thrivent Small-Mid Cap ESG ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
0.71%
OneAscent Enhanced Small and Mid Cap ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.67%
iShares S&P Small-Cap 600 Growth ETF
0.66%
Franklin US Small Cap Multifactor Index ETF
0.66%
詳細を見る
Invesco S&P SmallCap Health Care ETF
比率3.18%
First Trust Indxx Medical Devices ETF
比率2.22%
State Street SPDR S&P Health Care Equipment ETF
比率1.76%
Thrivent Small-Mid Cap ESG ETF
比率0.91%
Invesco S&P SmallCap Low Volatility ETF
比率0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
比率0.71%
OneAscent Enhanced Small and Mid Cap ETF
比率0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
比率0.67%
iShares S&P Small-Cap 600 Growth ETF
比率0.66%
Franklin US Small Cap Multifactor Index ETF
比率0.66%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Merit Medical Systems Incの上位5名の株主は誰ですか?

Merit Medical Systems Incの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は7.97M株を保有しており、これは全体の13.46%に相当します。
The Vanguard Group, Inc.は6.82M株を保有しており、これは全体の11.51%に相当します。
State Street Investment Management (US)は2.22M株を保有しており、これは全体の3.75%に相当します。
Conestoga Capital Advisors, LLCは2.21M株を保有しており、これは全体の3.73%に相当します。
Fuller & Thaler Asset Management Inc.は1.82M株を保有しており、これは全体の3.07%に相当します。

Merit Medical Systems Incの株主タイプ上位3種は何ですか?

Merit Medical Systems Incの株主タイプ上位3種は、
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)

Merit Medical Systems Inc(MMSI)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Merit Medical Systems Incの株式を保有している機関は736社あり、保有株式の総市場価値は約64.29Mで、全体の108.43%を占めています。2025Q2と比較して、機関の持ち株は-2.37%増加しています。

Merit Medical Systems Incの最大の収益源は何ですか?

FY2025Q2において、Peripheral Intervention部門がMerit Medical Systems Incにとって最大の収益を生み出しており、その金額は142.85Mで、全収益の37.35%を占めています。
KeyAI